MALCOLM; Thomas

Patent Applications and Registrations

Patent applications and USPTO patent grants for MALCOLM; Thomas.The latest application filed is for "compositions and methods for excision with single grna".

Company Profile

10.1.25

MALCOLM; Thomas - Andover NJ
Malcolm; Thomas - Bedminster NJ
Malcolm; Thomas - Badminster NJ

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Compositions And Methods For Excision With Single Grna App 20220290177 - MALCOLM; Thomas	2022-09-15
Methods Of Blocking Asfv Infection Through Interruption Of Cellular And Viral Receptor Interactions App 20220241391 - CHEN; Dalu ; et al.	2022-08-04
Tailored Hypoimmune Nanovesicular Delivery Systems For Cancer Tumors App 20220218842 - MALCOLM; Thomas	2022-07-14
Tailored Hypoimmune Nanovesicular Delivery Systems For Cancer Tumors, Hereditary And Infectious Diseases App 20220040106 - MALCOLM; Thomas ; et al.	2022-02-10
Compositions And Methods Of Treatment For Lytic And Lysogenic Viruses App 20200095586 - MALCOLM; Thomas	2020-03-26
Gene Editing Therapy For Hiv Infection Via Dual Targeting Of Hiv Genome And Ccr5 App 20190367924 - Khalili; Kamel ; et al.	2019-12-05
CLOAKED CRISPRs App 20190338315 - Malcolm; Thomas ; et al.	2019-11-07
CRISPRs IN SERIES TREATMENT App 20190336617 - Malcolm; Thomas	2019-11-07
Metabalomics And Viral Diagnostics Suite App 20190285632 - Malcolm; Thomas	2019-09-19
Gene Editing Methods And Compositions For Eliminating Risk Of Jc Virus Activation And Pml (progressive Multifocal Leukoencephalo App 20190247470 - Khalili; Kamel ; et al.	2019-08-15
Hiv Clinical Plan App 20190194652 - MALCOLM; Thomas	2019-06-27
Gene editing methods and compositions for eliminating risk of JC virus activation and PML (progressive multifocal leukoencephalopathy) during immunosuppressive therapy Grant 10,279,014 - Khalili , et al.	2019-05-07
Methods And Compositions Utilizing Cpf1 For Rna-guided Gene Editing App 20190083656 - Khalili; Kamel ; et al.	2019-03-21
Negative feedback regulation of HIV-1 by gene editing strategy App 20190085326 - Khalili; Kamel ; et al.	2019-03-21
CRISPRs WITH IMPROVED SPECIFICITY App 20190071673 - Malcolm; Thomas	2019-03-07
Rna Guided Eradication Of Human Jc Virus And Other Polyomaviruses App 20190038770 - KHALILI; Kamel ; et al.	2019-02-07
Methods And Compositions For Rna-guided Treatment Of Hiv Infection App 20190032057 - KHALILI; Kamel ; et al.	2019-01-31
Lentivirus And Non-integrating Lentivirus As Viral Vector To Deliver Crispr Therapeutic App 20180208914 - Malcolm; Thomas ; et al.	2018-07-26
CRISPRs App 20180201921 - Malcolm; Thomas	2018-07-19
Gene Editing Methods And Compositions For Eliminating Risk Of Jc Virus Activation And Pml (progressive Multifocal Leukoencephalopathy) During Immunosuppressive Therapy App 20180140682 - Khalili; Kamel ; et al.	2018-05-24

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.